rhFGF18

recombinant human fibroblast growth factor 18 · Merck KGaA

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for rhFGF18, covering 2014-06-25 to 2014-06-25. Get the full timeline:

Most recent: Clinical Trial Update: A Multicenter Study of rhFGF 18 in Patients With Knee Osteoarthritis Not Requiring Surgery [Phase 1]